FDA draft guidance on transdermal systems [BE/BA News]

posted by Ohlbe – France, 2023-04-13 10:37 (811 d 19:54 ago) – Posting: # 23523
Views: 2,390

Dear all,

If you're working on transdermal and topical delivery systems, you will be interested in two new FDA draft guidance documents:
- one on the assessment of irritation and sensitisation potential;
- one on the assessment of adhesion.

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,425 posts in 4,928 threads, 1,683 registered users;
54 visitors (0 registered, 54 guests [including 12 identified bots]).
Forum time: 06:31 CEST (Europe/Vienna)

You can do one of two things; just shut up,
which is something I don’t find easy,
or learn an awful lot very fast,
which is what I tried to do.    Jane Fonda

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5